Driver 360 vs RxVantage for Reps Utilisation & Stats

Driver 360 provided by EMKAY, Inc. is the fleet industry’s premier driver focused fleet management iPhone application. Driver 360 enables EMKAY fleet drivers to perform necessary fleet functions and view valuable information regarding their fleet vehicle right from their iPhone.
  • Apple App Store
  • Gratuit
  • Entreprises

Classement dans le store

- -

This new app gives Premium and Enterprise users a central place to manage their entire RxVantage account on any mobile device. We’ve redesigned the app to optimize it for iPhone and iPad and make it faster and easier for you to complete your most important tasks to better serve your customers. RxVantage connects healthcare providers to the precise life science experts they need, when they need them, to improve patient care. The app helps life science experts to better serve providers by making it easy to book meetings, respond to practice requests, and communicate with practice staff, from anywhere. * Instant push notifications for available appointments with your target practices * View all customers in your territory * View practice calendars and schedules * Book and confirm meetings online * Access to your target practice’s rules and preferences * Receive reminders and practice requests * Collaborate with your teammates and exchange appointments The app is free to all RxVantage Premium and Enterprise users.
  • Apple App Store
  • Gratuit
  • Entreprises

Classement dans le store

- -

Comparaison des classements Driver 360 vs. RxVantage for Reps

Comparez l'évolution du classement de Driver 360 au cours des 28 derniers jours à celle de RxVantage for Reps.

Rank

Aucune donnée disponible

Comparaison des classements Driver 360 et RxVantage for Reps par pays

Comparez l'évolution du classement de Driver 360 au cours des 28 derniers jours à celle de RxVantage for Reps.

Aucune donnée à afficher

Comparez avec n'importe quel site grâce à notre essai gratuit

Démarrer
Driver 360 VS.
RxVantage for Reps

25écembre d, 2024